APA (7th ed.) Citation

Ghazi, N., Alkuraya, F., Al-Maghamsi, A., Al Saikhan, F., & Abboud, E. (2013). Phase I trial of subretinal injection of a recombinant adeno-associated virus (rAAV2-VMD2-hMERTK) gene vector to patients with MERTK RP.

Chicago Style (17th ed.) Citation

Ghazi, Nicola, Fowzan Alkuraya, Abdulrahman Al-Maghamsi, Fahad Al Saikhan, and Emad Abboud. Phase I Trial of Subretinal Injection of a Recombinant Adeno-associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with MERTK RP. 2013.

MLA (9th ed.) Citation

Ghazi, Nicola, et al. Phase I Trial of Subretinal Injection of a Recombinant Adeno-associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with MERTK RP. 2013.